These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29712958)

  • 1. Structural characteristics and membrane interactions of tandem α-synuclein oligomers.
    Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT
    Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the non-fibrillar α-synuclein oligomers.
    Hong DP; Han S; Fink AL; Uversky VN
    Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers.
    Stöckl M; Claessens MM; Subramaniam V
    Mol Biosyst; 2012 Jan; 8(1):338-45. PubMed ID: 22009045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
    Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
    Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.
    Högen T; Levin J; Schmidt F; Caruana M; Vassallo N; Kretzschmar H; Bötzel K; Kamp F; Giese A
    Biophys J; 2012 Apr; 102(7):1646-55. PubMed ID: 22500765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.
    Hong DP; Fink AL; Uversky VN
    J Mol Biol; 2008 Oct; 383(1):214-23. PubMed ID: 18775438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
    Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
    FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
    Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT
    Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein amyloid oligomers act as multivalent nanoparticles to cause hemifusion in negatively charged vesicles.
    Stefanovic AN; Claessens MM; Blum C; Subramaniam V
    Small; 2015 May; 11(19):2257-62. PubMed ID: 25641873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers.
    Nübling GS; Levin J; Bader B; Lorenzl S; Hillmer A; Högen T; Kamp F; Giese A
    PLoS One; 2014; 9(6):e98906. PubMed ID: 24911099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein oligomers induced by docosahexaenoic acid affect membrane integrity.
    Fecchio C; De Franceschi G; Relini A; Greggio E; Dalla Serra M; Bubacco L; Polverino de Laureto P
    PLoS One; 2013; 8(11):e82732. PubMed ID: 24312431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
    Alam P; Bousset L; Melki R; Otzen DE
    J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High stability and cooperative unfolding of α-synuclein oligomers.
    Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
    Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and Characterization of α-Synuclein Oligomers.
    Paslawski W; Lorenzen N; Otzen DE
    Methods Mol Biol; 2016; 1345():133-50. PubMed ID: 26453210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes.
    van Maarschalkerweerd A; Vetri V; Vestergaard B
    FEBS Lett; 2015 Sep; 589(19 Pt B):2661-7. PubMed ID: 26297828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.
    Gallea JI; Celej MS
    J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein Oligomers Stabilize Pre-Existing Defects in Supported Bilayers and Propagate Membrane Damage in a Fractal-Like Pattern.
    Chaudhary H; Iyer A; Subramaniam V; Claessens MM
    Langmuir; 2016 Nov; 32(45):11827-11836. PubMed ID: 27766878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.